Manatuck Hill Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-39,600
Closed -$667K 112
2022
Q4
$667K Sell
39,600
-3,700
-9% -$61K 0.32% 63
2022
Q3
$506K Sell
43,300
-6,700
-13% -$95.7K 0.26% 64
2022
Q2
$788K Sell
50,000
-50,000
-50% -$840K 0.39% 54
2022
Q1
$1.55M Buy
+100,000
New +$1.26M 0.6% 48

Other funds holding PTEN

Manatuck Hill Partners's PTEN Position: Q1 2023 in Review

Manatuck Hill Partners sold out of Patterson-UTI (PTEN) in Q1 2023, closing a stake of 39,600 shares — an estimated $667K sold.

Manatuck Hill Partners first reported a position in PTEN in Q1 2022 and held it in 4 quarters. The position peaked at $1.55M in Q1 2022. 285 funds tracked by Wall St. Rank hold PTEN as of Q1 2023.

  • Manatuck Hill Partners reported no remaining Patterson-UTI position as of Q1 2023 after selling out during the quarter.
  • Manatuck Hill Partners sold 39,600 Patterson-UTI shares in Q1 2023, an estimated $667K.
  • Manatuck Hill Partners first reported a position in Patterson-UTI in Q1 2022 and held it in 4 quarters.
  • Manatuck Hill Partners's Patterson-UTI position peaked at $1.55M in Q1 2022.
  • 285 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2023.

Based on Manatuck Hill Partners's 13F filing for Q1 2023, filed 15 May 2023.